Correction and clarification concerning the expiry dates of AcuCort’s patents
AcuCort AB (AktieTorget: ACUC) today makes a correction and clarification concerning patent terms and expiry dates for the company’s granted patents for medical formulations containing glucocorticoids for self-treatment in acute situations without access to medical personnel, “Acute Glucocorticoid Therapy”.On April 16, 2018 AcuCort announced that the company’s patent for the above invention was granted in the US (patent no 9,925,139, B2) and that the US Patent and Trademark Office (USPTO) had extended the patent term by 1,349 days in accordance with US patent law, as the patent authority